Injectable Decm-Enhanced Hyaluronic Microgels with Spatiotemporal Release of Cartilage-Specific Molecules to Improve Osteoarthritic Chondrocyte’s Function

Siyan Deng,Hongfu Cao,Yan Lu,Wenqing Shi,Manyu Chen,Xiaolin Cui,Jie Liang,Yujiang Fan,Qiguang Wang,Xingdong Zhang
DOI: https://doi.org/10.1186/s42825-024-00158-6
2024-01-01
Collagen and Leather
Abstract:The interior environment of articular cartilage in osteoarthritis (OA) presents substantial hurdles, leading to the malfunction of chondrocytes and the breakdown of collagen II-enriched hyaline cartilage matrix. Despite this, most clinical treatments primarily provide temporary relief from OA discomfort without arresting OA progression. This study aimed to alleviate OA by developing intra-articular injectable dECM-enhanced hyaluronic (HE) microgels. The HE hydrogel was engineered and shaped into uniformly sized microgels using microfluidics and photopolymerization techniques. These microgels provided a spatiotemporal cascade effect, facilitating the rapid release of growth factors and a slower release of ECM macromolecules and proteins. This process assisted in the recovery of OA chondrocytes’ function, promoting cell proliferation, matrix synthesis, and cartilage-specific gene expression in vitro. It also effectively aided repair of the collagen II-enriched hyaline cartilage and significantly reduced the severity of OA, as demonstrated by radiological observation, gross appearance, histological/immunohistochemical staining, and analysis in an OA rat model in vivo. Collectively, the HE injectable microgels with spatiotemporal release of cartilage-specific molecules have shown promise as a potential candidate for a cell-free OA therapy approach.
What problem does this paper attempt to address?